Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

PROCEPT BioRobotics (PRCT) EPS (Basic) (2020 - 2025)

PROCEPT BioRobotics has reported EPS (Basic) over the past 6 years, most recently at -$0.53 for Q4 2025.

  • Quarterly results put EPS (Basic) at -$0.53 for Q4 2025, down 55.88% from a year ago — trailing twelve months through Dec 2025 was -$1.71 (up 2.29% YoY), and the annual figure for FY2025 was -$1.72, up 1.71%.
  • EPS (Basic) for Q4 2025 was -$0.53 at PROCEPT BioRobotics, down from -$0.38 in the prior quarter.
  • Over the last five years, EPS (Basic) for PRCT hit a ceiling of $2.01 in Q4 2021 and a floor of -$2.65 in Q1 2021.
  • Median EPS (Basic) over the past 5 years was -$0.51 (2022), compared with a mean of -$0.61.
  • Biggest five-year swings in EPS (Basic): surged 164.22% in 2021 and later plummeted 131.34% in 2022.
  • PROCEPT BioRobotics' EPS (Basic) stood at $2.01 in 2021, then plummeted by 131.34% to -$0.63 in 2022, then increased by 14.29% to -$0.54 in 2023, then surged by 37.04% to -$0.34 in 2024, then tumbled by 55.88% to -$0.53 in 2025.
  • The last three reported values for EPS (Basic) were -$0.53 (Q4 2025), -$0.38 (Q3 2025), and -$0.35 (Q2 2025) per Business Quant data.